Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
life sciences
microbiome
5
×
national blog main
new york blog main
new york top stories
pfizer
5
×
san francisco blog main
san francisco top stories
boston top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
amgen
astrazeneca
bristol-myers squibb
cancer
deals
eli lilly
fda
investing
merck
What
bio
roundup
drug
days
fda
microbiome
news
acquisitions
advantages
approved
august
babies
bar
biggest
biotech
birth
born
breastfeed
brings
build
busy
buy
ceo
companies
company’s
daniel
debut
decisions
devices
digital
disease
drugs
dyne’s
epidemic
expect
fatty
frenzied
gamble
gilead
giving
Language
unset
Current search:
microbiome
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
